Molecular docking results demonstrated that key active phytochemicals of Cnidium monnieri can potentially bind to HCC-related targets (EGFR, CASP3, ESR1, MAPK3, CCND1, and ERBB2). This evidence concerns the gene MAPK3 and hepatocellular carcinoma.